It is my pleasure to share our new work with immunology community! We can achieve selective targeting by exploiting immunometabolism😋Thanks for all collaborators!#immunometabolism #cancerimmunoyherqpy @NatImmunol @OncoUNILCHUV @Ludwig_Cancer https://t.co/KETkchOTzS
Proud to be one of them in a, hopefully, increasingly equalitary sector
#WomenInScienceDay #11F https://t.co/t2EnZ5hHwg
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat